Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China

Zhongjie Li(Capital Medical University), George F. Gao(Chinese Academy of Sciences), Zhijie An(Ningxia University), Naiying Mao(Centers for Disease Control and Prevention), Lance E. Rodewald, Wenqing Yao(Tsinghua University), Xiaodong Sun(Shanghai Municipal Center For Disease Control Prevention), Zhen Zhu(Center for Disease Control), Xuemei Su(Chinese Center For Disease Control and Prevention), Xingfen Yang(Key Laboratory of Guangdong Province), Na He(Fudan University), Bike Zhang(National Institute for Communicable Disease Control and Prevention), Jianhua Liu(Changchun University of Science and Technology), Ming Wu(Wuhan Pulmonary Hospital), Yu Li(Chinese Center For Disease Control and Prevention), Jun Liu(Chongqing Population and Family Planning Science and Technology Research Institute), Liping Wang(Guilin University of Technology), Xiaoli Wang(Beijing Center for Disease Prevention and Control), Qing Guo(Hunan University), Wenjing Gao(Peking University), Zijian Feng(Huazhong Agricultural University), Junling Sun(Chinese Center For Disease Control and Prevention), Liming Li(Peking University), Ying Qin(The People's Hospital of Guangxi Zhuang Autonomous Region), Jianxing Yu(Chinese Center For Disease Control and Prevention), Tie Song(Guangdong Provincial Center for Disease Control and Prevention), Wenbo Xu(Shenyang Institute of Automation), Zhibin Peng(Chinese Center For Disease Control and Prevention), Huiming Luo(Wuhan University), Nijuan Xiang(Chinese Center For Disease Control and Prevention), Hongbing Shen(Jiangsu Cancer Hospital), Xuhua Guan(Hubei Provincial Center for Disease Control and Prevention), Xianping Wu(Guangzhou University of Chinese Medicine)
The Lancet Regional Health - Western Pacific
February 7, 2021
Cited by 57


Related Papers